Evaluation of the epstein-barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms

Journal of Molecular Diagnostics

Volumn 10, Issue 1, 2008, Pages 78-84

  Fafi Kremer, Samira ^a,b   Morand, Patrice ^a   Barranger, Come ^c   Barguès, Gérard ^a   Magro, Stéphane ^c   Bés, Jérôme ^c   Bourgeois, Philippe ^c   Joannes, Martine ^c   Seigneurin, Jean Marie ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c Argene Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BIOASSAY; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; DNA EXTRACTION; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; INFECTIOUS MONONUCLEOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; ORGAN TRANSPLANTATION; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS CARRIER; VIRUS GENE; VIRUS INFECTION; VIRUS LOAD;

HUMAN HERPESVIRUS 4;

EID: 38749144038     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2008.070054     Document Type: Article

References (26)

1. Cohen JI: Epstein-Barr virus infection. N Engl J Med 2000, 343:481-492
2. Thorley-Lawson DA, Gross A: Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004, 350:1328-1337
3. Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757-768
4. Gottschalk S, Rooney CM, Heslop HE: Post-transplant lymphoproliferative disorders. Annu Rev Med 2005, 56:29-44
5. Fan H, Nicholls J, Chua D, Chan KH, Sham J, Lee S, Gulley ML: Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus. Int J Cancer 2004, 112:1036-1041
6. Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF: Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol 2005, 23:7604-7613
7. Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S: Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005, 80:64-69
8. Young LS, Murray PG: Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 2003, 22:5108-5121
9. Fafi-Kremer S, Morand P, Brion JP, Pavese P, Baccard M, Germi R, Genoulaz O, Nicod S, Jolivet M, Ruigrok RW, Stahl JP, Seigneurin JM: Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis. J Infect Dis 2005, 191:985-989
10. van Laar JA, Buysse CM, Vossen AC, Hjalmarsson B, van Den Berg B, van Lom K, Deinum J: Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis. Arch Intern Med 2002, 162:837-839
11. Fafi-Kremer S, Brengel-Pesce K, Bargues G, Bourgeat MJ, Genoulaz O, Seigneurin JM, Morand P: Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. J Clin Virol 2004, 30:157-164
12. Stevens SJ, Prank I, Middeldorp JM: Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol 2001, 39:1211-1216
13. Beuselinck K, van Ranst M, van Eldere J: Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR. J Clin Microbiol 2005, 43:5541-5546
14. Brengel-Pesce K, Morand P, Schmuck A, Bourgeat MJ, Buisson M, Bargues G, Bouzid M, Seigneurin JM: Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol 2002, 66:360-369
15. Choquet S, Leblond V, Herbrecht R, Socie G, Stoppa AM, Vandenberghe P, Fischer A, Morschhauser F, Salles G, Feremans W, Vilmer E, Peraldi MN, Lang P, Lebranchu Y, Oksenhendler E, Garnier JL, Lamy T, Jaccard A, Ferrant A, Offner F, Hermine O, Moreau A, Fafi-Kremer S, Morand P, Chatenoud L, Berriot-Varoqueaux N, Bergougnoux L, Milpied N: Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood 2006, 107:3053-3057
16. Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD: Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000, 38:712-715
17. Stevens SJ, Verkuijlen SA, Brule AJ, Middeldorp JM: Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimens. J Clin Microbiol 2002, 40:3986-3992
18. Gulley ML, Fan H, Elmore SH: Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting. J Mol Diagn 2006, 8:589-597
19. Hill CE, Harris SB, Culler EE, Zimring JC, Nolte FS, Caliendo AM: Performance characteristics of two real-time PCR assays for the quantification of Epstein-Barr virus DNA. Am J Clin Pathol 2006, 125:665-671
20. Kozic S, Vince A, Bes JI, Rode OD, Lepej SZ, Poljak M, Bozic M, Kessler HH: Evaluation of a commercial real-time PCR assay for quantitation of Epstein-Barr virus DNA in different groups of patients. J Virol Methods 2006, 135:263-268
21. Ruiz G, Pena P, de Ory F, Echevarria JE: Comparison of commercial real-time PCR assays for quantification of Epstein-Barr virus DNA. J Clin Microbiol 2005, 43:2053-2057
22. Bonnet F, Jouvencel AC, Parrens M, Leon MJ, Cotto E, Garrigue I, Morlat P, Beylot J, Fleury H, Lafon ME: A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. J Clin Virol 2006, 36:258-263
23. Wagner HJ, Wessel M, Jabs W, Smets F, Fischer L, Offner G, Bucsky P: Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation 2001, 72:1012-1019
24. Hakim H, Gibson C, Pan J, Srivastava K, Gu Z, Bankowski MJ, Hayden RT: Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus (EBV) in peripheral blood. J Clin Microbiol 2007, 45:2151-2155
25. Wada K, Kubota N, Ito Y, Yagasaki H, Kato K, Yoshikawa T, Ono Y, Ando H, Fujimoto Y, Kiuchi T, Kojima S, Nishiyama Y, Kimura H: Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol 2007, 45:1426-1432
26. Boom R, Sol CJ, Schuurman T, Van Breda A, Weel JF, Beld M, Ten Berge IJ, Wertheim-Van Dillen PM, De Jong MD: Human cytomegalovirus DNA in plasma and serum specimens of renal transplant recipients is highly fragmented. J Clin Microbiol 2002, 40:4105-4113